ENRIQUE
ALAVA CASADO
Investigador en el periodo 2012-2013
Publicaciones (55) Publicaciones de ENRIQUE ALAVA CASADO
2019
-
Preclinical efficacy of endoglin-targeting antibody–drug conjugates for the treatment of Ewing sarcoma
Clinical Cancer Research, Vol. 25, Núm. 7, pp. 2228-2240
2017
-
GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish sarcoma group (GEIS)
British Journal of Cancer, Vol. 117, Núm. 6, pp. 767-774
2016
-
Concordance study between one-step nucleic acid amplification and morphologic techniques to detect lymph node metastasis in papillary carcinoma of the thyroid
Human Pathology, Vol. 48, pp. 132-141
-
Molecular pathology of bone and soft tissue tumors
The Molecular Basis of Human Cancer (Springer New York), pp. 623-655
-
Proteomic Profiling of Ewing Sarcoma Reveals a Role for TRAF6 in Proliferation and Ribonucleoproteins/RNA Processing
Journal of Proteomics & Bioinformatics, Vol. 09, Núm. 06
-
Sarcoma histiocítico en intestino delgado: estudio y discusión de un caso con reordenamiento clonal linfoide B
Revista Espanola de Patologia, Vol. 49, Núm. 4, pp. 254-258
2015
-
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Oncotarget, Vol. 6, Núm. 22, pp. 18875-18890
-
Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents
Clinical Cancer Research, Vol. 21, Núm. 6, pp. 1373-1382
2014
-
Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications
PLoS ONE, Vol. 9, Núm. 2
-
Contribution of the R-Ras2 GTP-binding protein to primary breast tumorigenesis and late-stage metastatic disease
Nature Communications, Vol. 5
-
Innovative therapies in ewing sarcoma
Advances in Anatomic Pathology, Vol. 21, Núm. 1, pp. 44-62
-
Tumor desmoplásico de células pequeñas y redondas en pared torácica
Revista Espanola de Patologia, Vol. 47, Núm. 1, pp. 41-44
2013
-
EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1
PLoS ONE, Vol. 8, Núm. 8
-
Fluorescence in situ hybridization analysis of CCND3 gene as marker of progression in bladder carcinoma
Journal of Biological Regulators and Homeostatic Agents, Vol. 27, Núm. 2, pp. 559-567
-
Round Cell Tumors
Practical Soft Tissue Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series (Elsevier), pp. 221-234
-
The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis
Carcinogenesis, Vol. 34, Núm. 2, pp. 268-276
-
WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells
Oncogene, Vol. 32, Núm. 11, pp. 1441-1451
2012
-
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma
Oncogene, Vol. 31, Núm. 10, pp. 1287-1298
-
A new multidisciplinary Spanish Working Group on Cancer Biomarkers: Presentation and aims
Clinical and Translational Oncology
-
Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome
Pediatric Blood and Cancer, Vol. 58, Núm. 4, pp. 532-538